Medtide Inc Sustainability Reports
Medtide Inc. operates as a contract research, development, and manufacturing organization (CRDMO) focusing on peptide and oligonucleotide therapies.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 254900EYF65J0WV87333
FIGI: BBG01VCMW6X3
1 reports from 2025 to 2025
